Benzamidines, alkamidines and formamidines formed by use of aryl- and alkyliminodimagnesium: Molar ratio and structure of reagent governing the reaction
摘要:
In order to extend the the method for preparation of amidines using N-Mg reagents, aryl- and alkyliminodimagnesium [IDMg, ArN(MgBr)(2) and RN(MgBr)(2)] were reacted with esters, amides, ortho- esters, acetals, aminoacetal and arene- and alkane carbonitriles, Among the compounds used, aminoacetal and carbonitriles were proved to be useful as starting materials for amidine preparation; alkyl-IDMgs were successfully used for the first time, It was noted that an excess molar amount of IDMg is needed in the reported reaction of ArN(MgBr), with benzonitrile (aryl-aryl combination), whereas no excess is needed in aryl-alkyl, alkyl-aryl, and alkyl-alkyl combinations of reagent and substrate, From the viewpoint previously proposed in terms of relative efficiency of single electron transfer in the reactions of magnesium reagents, the most probable reason for the difference in the need for an excess molar amount of aryl and alkyl IDMg was ascribed to the difference in the electron-donating abilities of reagents, Additional minor reasons are discussed.
Tetracoordinate borates as catalysts for reductive formylation of amines with carbon dioxide
作者:Xiaolin Jiang、Zijun Huang、Mohamed Makha、Chen-Xia Du、Dongmei Zhao、Fang Wang、Yuehui Li
DOI:10.1039/d0gc01741h
日期:——
We report sodium trihydroxyaryl borates as the first robust tetracoordinate organoboron catalysts for reductive functionalization of CO2. These catalysts, easily synthesized from condensing boronic acids with metal hydroxides, activate main group element–hydrogen (E–H) bonds efficiently. In contrast to BX3 type boranes, boronic acids and metal-BAr4 salts, under transition metal-free conditions, sodium
[EN] ANTIVIRAL PYRAZOLOPYRIDINONE COMPOUNDS<br/>[FR] COMPOSÉS ANTIVIRAUX DE PYRAZOLOPYRIDINONE
申请人:NOVARTIS AG
公开号:WO2021061898A1
公开(公告)日:2021-04-01
The invention provides compounds of Formula (I) as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by herpesviruses.
Hydrophosphination of CO<sub>2</sub>and Subsequent Formate Transfer in the 1,3,2-Diazaphospholene-Catalyzed<i>N</i>-Formylation of Amines
作者:Che Chang Chong、Rei Kinjo
DOI:10.1002/anie.201505244
日期:2015.10.5
Hydrophosphination of CO2 with 1,3,2‐Diazaphospholene (NHP‐H; 1) afforded phosphorus formate (NHP‐OCOH; 2) through the formation of a bond between the electrophilic phosphorus atom in 1 and the oxygen atom from CO2, along with hydride transfer to the carbon atom of CO2. Transfer of the formate from 2 to Ph2SiH2 produced Ph2Si(OCHO)2 (3) in a reaction that could be carried out in a catalytic manner
Diverse catalytic reactivity of a dearomatized PN<sup>3</sup>P*–nickel hydride pincer complex towards CO<sub>2</sub> reduction
作者:Huaifeng Li、Théo P. Gonçalves、Qianyi Zhao、Dirong Gong、Zhiping Lai、Zhixiang Wang、Junrong Zheng、Kuo-Wei Huang
DOI:10.1039/c8cc05948a
日期:——
A dearomatized PN3P*–nickel hydridecomplex has been prepared using an oxidative addition process. The first nickel-catalyzed hydrosilylation of CO2 to methanol has been achieved, with unprecedented turnover numbers. Selective methylation and formylation of amines with CO2 were demonstrated by such a PN3P*–nickel hydridecomplex, highlighting its versatile functions in CO2 reduction.
使用氧化加成法制备了脱芳香化的PN 3 P *-氢化镍配合物。首次实现了镍催化的CO 2加氢硅烷化为甲醇,其转化率空前。此类PN 3 P *-氢化镍氢化物证明了胺与CO 2的选择性甲基化和甲酰化,突出了其在CO 2还原中的多功能性。
Substituted piperidines and methods of use
申请人:——
公开号:US20040006067A1
公开(公告)日:2004-01-08
Selected substituted piperidine compounds are effective for prophylaxis and treatment of diseases, such as obesity and the like. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving activation of the melanocortin receptor. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.